Diagnosis and management of pediatric retinal conditions such as retinopathy of prematurity
(ROP) have been evolving significantly with the availability of new technology and
treatments. New imaging systems, telemedicine, tele-education, and anti-vascular
endothelial growth factor (VEGF) intravitreal pharmacotherapy are all changing the way we
diagnose and deliver care to children with pediatric retinal disease. Fluorescein
angiography and optical coherence tomography have the potential to improve our diagnosis …